Gebhardt R
Physiologisch-chemisches Institut, Universität Tübingen, Fed. Rep. of Germany.
Arzneimittelforschung. 1991 Aug;41(8):800-4.
Cultured rat hepatocytes continually synthesize cholesterol form radiolabeled acetate during a 24 h incubation period and export it, presumably as VLDL (very low density lipoprotein) to the culture medium. Mevastatin inhibits cholesterol biosynthesis by 90%. Incubation of the cultures with water-soluble extracts of garlic powder (Kwai, Sapec) diminish cholesterol biosynthesis (20-25%) as well as its export into the medium (30-35%). The IC50-value is 90 micrograms/ml. Between about 0.25 and 10 mg/ml the average maximal inhibition amounts to about 23%. Cytotoxicity of the extracts is apparent at concentrations above 125 mg/ml only. Pure alliin alone, or after incubation with alliinase (conversion to allicin) in concentrations corresponding to its content in the extracts does not exert any inhibition. Replacement of 14C-acetate by 14C-mevalonate omits the inhibitory effect. The activity of HMGCoA (hydroxymethylglutaryl-CoA) reductase is significantly reduced by garlic extracts at 50 micrograms/ml. At higher concentrations fatty acid synthetase, cholesterol 7 alpha-hydroxylase and cholesterol acyltransferase are slightly inhibited. Fatty acid synthetase is the only one of these enzymes which is inhibited by alliin at very high concentrations. These results demonstrate that water-soluble garlic extracts diminish hepatic cholesterol biosynthesis, thus contributing to the reduction of blood cholesterol. The main target site seems to be HMGCoA-reductase. The actual active principle(s) is still unknown. Alliin, however, does not seem to be of major significance.
培养的大鼠肝细胞在24小时的孵育期内持续从放射性标记的乙酸盐合成胆固醇,并将其输出,推测是以极低密度脂蛋白(VLDL)的形式输出到培养基中。美伐他汀可抑制90%的胆固醇生物合成。用大蒜粉(Kwai,Sapec)的水溶性提取物孵育培养物,可减少胆固醇生物合成(20 - 25%)及其向培养基中的输出(30 - 35%)。半数抑制浓度(IC50)值为90微克/毫升。在约0.25至10毫克/毫升之间,平均最大抑制率约为23%。提取物的细胞毒性仅在浓度高于125毫克/毫升时才明显。单独的纯蒜氨酸,或与蒜氨酸酶孵育后(转化为蒜素),在与提取物中含量相当的浓度下不会产生任何抑制作用。用14C - 甲羟戊酸替代14C - 乙酸盐可消除抑制作用。50微克/毫升的大蒜提取物可显著降低3 - 羟基 - 3 - 甲基戊二酰辅酶A(HMGCoA)还原酶的活性。在较高浓度下,脂肪酸合成酶、胆固醇7α - 羟化酶和胆固醇酰基转移酶会受到轻微抑制。脂肪酸合成酶是这些酶中唯一在非常高浓度下会被蒜氨酸抑制的酶。这些结果表明,水溶性大蒜提取物可减少肝脏胆固醇生物合成,从而有助于降低血液胆固醇。主要靶点似乎是HMGCoA还原酶。实际的活性成分仍然未知。然而,蒜氨酸似乎并不起主要作用。